NK KRX:085310KOSPI

엔케이 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days12
DART filings, 7 days0
Articles tracked94since Sep 11

In Q2 2026, NK reported revenue of ₩36.8bn, up 28.8% year on year, and operating profit of ₩3.1bn. NK (엔케이) appeared in 12 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 20 with 10 articles. The most common catalyst was clinical & approvals (4). It was most often mentioned alongside GC Cell.

Filing signals Buyback Supply contract Screener

NK quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩36.8bn+28.8%₩3.1bn
margin 8.5%
₩3.6bn
Q1 2026₩31.9bn+33.3%₩534m
margin 1.7%
₩2.9bn
Q4 2025 derived₩49.0bn+36.3%₩5.0bn
margin 10.2%
₩1.2bn
Q3 2025₩28.6bn+19.7%−₩5.0bn
margin −17.6%
−₩2.9bn
Q2 2025₩28.6bn+11.7%₩340m
margin 1.2%
−₩1.7bn
Q1 2025₩23.9bn-6.2%−₩962m
margin −4.0%
−₩356m
Q4 2024 derived₩36.0bn+57.1%−₩1.4bn
margin −4.0%
₩2.4bn
Q3 2024₩23.9bn+37.5%−₩1.3bn
margin −5.6%
−₩2.7bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

NK top stories 2 weeks, by number of outlets

  1. 1
    엔케이, 30억 규모 자사주 매입 조기 완료…추가 신탁계약 체결
    5 outlets · 5 articlesFirst report Oct 20 08:26 뉴시스경제
  2. 2
    지씨셀, CD5 CAR-NK 치료제 'GCC2005' 임상 성과 국제학술행사서 공개
    2 outlets · 2 articlesFirst report Oct 28 10:38 메디컬투데이GC Cell
  3. 3
    엔케이, 30억원 규모 자사주 신탁 계약 체결
    2 outlets · 2 articlesFirst report Oct 20 08:11 컨슈머타임스
  4. 4
    엔케이, 30억원 규모 자기주식취득 신탁계약 해지 결정
    1 outlets · 2 articlesFirst report Oct 19 11:11 디지털투데이Stake / acquisition
  5. 5
    〔오늘의 NK 미디어 브리핑〕 2026년 10월 17일
    1 outlets · 2 articlesFirst report Oct 17 22:33 SPN 서울평양뉴스
  6. 6
    지씨셀, 림프종 국제 학술행사서 CD5 표적 CAR-NK 1a상 중간 결과 발표
    1 outlets · 1 articlesFirst report Oct 28 11:44 더바이오Clinical trialGC Cell

Latest NK news Korean headlines